Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Precision BioSciences

Precision BioSciences
2006 FOUNDED
PUBLIC STATUS
101-200 EMPLOYEES
DTIL STOCK SYMBOL
$14.72 SHARE PRICE (As of Friday Closing)
Description

Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The company's segments include Therapeutics and Food.

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Stock Exchange
NAS
Primary Office
  • 302 East Pettigrew Street
  • Dibrell Building, Suite A-100
  • Durham, NC 27701
  • United States

+1 (919) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Precision BioSciences’s full profile, request a free trial.

Precision BioSciences Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$11.77 - $19.00 $741M $15.05 -$2.79 248K 50.4M

Precision BioSciences Financials Summary

In Thousands,
USD
TTM
31-Mar-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
Enterprise Value 776,878
Revenue 14,817 10,883 6,484
EBITDA (68,044) (45,558) (20,539)
Net Income (68,808) (46,037) (21,102)
Total Assets 166,801 138,600 72,682
Total Debt 52,440
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Precision BioSciences Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Precision BioSciences‘s full profile, request access.

Request full access to PitchBook

Precision BioSciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is reserved for PitchBook Platform users. To explore Precision BioSciences‘s full profile, request access.

Request full access to PitchBook
To view this company’s complete Cap Table, request access »

Precision BioSciences Competitors (22)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Renova Therapeutics Venture Capital-Backed San Diego, CA 000.00 00000000000 000.00
00000 Formerly PE-Backed Paris, France 00 00000 00000000000 00000
0000000 0000000000 Formerly VC-backed Richmond, CA 000 000.00 00000000 000.00
000000 00000000000 Formerly VC-backed Zug, Switzerland 000 00000 00000000000 00000
000000 00000000 Formerly VC-backed Cambridge, MA 000 00000 00000000000 00000
To view this company’s complete list of competitors, request access »

Precision BioSciences Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Precision BioSciences‘s full profile, request access.

Request full access to PitchBook

Precision BioSciences Executive Team (12)

Name Title Board
Seat
Contact
Info
Matthew Kane Co-Founder, Chief Executive Officer & Board Member
Abid Ansari Chief Financial Officer
Jeff Smith Ph.D Co-Founder & Chief Technology Officer
David Thomson Ph.D Chief Development Officer
Derek Jantz Co-Founder, Chief Scientific Officer & Board Member

3 Former Executives

You’re viewing 5 of 12 executives. Get the full list »

Precision BioSciences Board Members (6)

Name Representing Role Since Contact
Info
Derek Jantz Precision BioSciences Co-Founder, Chief Scientific Officer & Board Member 000 0000
Matthew Kane Precision BioSciences Co-Founder, Chief Executive Officer & Board Member 000 0000
Robert Adelman MD venBio Board Member 000 0000
Shalini Sharp Self Board Member 000 0000
Tony Yao Self Board Member 000 0000

1 Former Board Member

You’re viewing 5 of 6 board members. Get the full list »